» Articles » PMID: 121258

[Semi-synthesis and Proposed Structure of Platelet-activating Factor (P.A.F.): PAF-acether an Alkyl Ether Analog of Lysophosphatidylcholine]

Overview
Specialty Biology
Date 1979 Nov 26
PMID 121258
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

We have studied the molecular structure of platelet-activating factor" (P.A.F.), a mediator of inflammation obtained from blood leukocytes, macrophages, and platelets themselves. We have semi-synthetized a substance that possesses all the known physicochemical and biological characteristics of P.A.F. from hog leukocytes. This was performed by successive methylation, hydrogenation, and acetylation of lysophosphatidylethanolamine plasmalogen. We therefore propose the following structure for P.A.F.: 1-0-alkyl-2-acetyl-glyceryl-3-phosphorylcholine. This molecular structure is not yet described among the numerous substances capable of inducing platelet aggregation and release.

Citing Articles

Tricky Isomers-The Evolution of Analytical Strategies to Characterize Plasmalogens and Plasmanyl Ether Lipids.

Koch J, Watschinger K, Werner E, Keller M Front Cell Dev Biol. 2022; 10:864716.

PMID: 35573699 PMC: 9092451. DOI: 10.3389/fcell.2022.864716.


Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives.

Lordan R, Tsoupras A, Zabetakis I, Demopoulos C Molecules. 2019; 24(23).

PMID: 31816871 PMC: 6930554. DOI: 10.3390/molecules24234414.


The role of lipids in the inception, maintenance and complications of dengue virus infection.

Melo C, Delafiori J, Dabaja M, de Oliveira D, Guerreiro T, Colombo T Sci Rep. 2018; 8(1):11826.

PMID: 30087415 PMC: 6081433. DOI: 10.1038/s41598-018-30385-x.


Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation.

Yamashita A, Hayashi Y, Matsumoto N, Nemoto-Sasaki Y, Koizumi T, Inagaki Y Biology (Basel). 2017; 6(2).

PMID: 28358327 PMC: 5485470. DOI: 10.3390/biology6020023.


Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma.

Onuchic A, Machado C, Saito R, Rios F, Jancar S, Chammas R Mediators Inflamm. 2012; 2012:175408.

PMID: 22570511 PMC: 3337612. DOI: 10.1155/2012/175408.